Results seem good. I believe that they were waiting for the trials to be finished and the Cohort Review Comittee to up the dosage to 100 µg before commencing the study with Pembrolizumab. Explains the delay in beginning that study.
Ann: Final HER-Vaxx Phase 2 Trial Overall Survival Results, page-58
-
- There are more pages in this discussion • 382 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.8¢ |
Change
0.004(6.48%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $1.818M | 32.96M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 713878 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 2066398 | 28 |
View Market Depth
| Last trade - 13.51pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |